睾酮皮下注射治疗:安全、实用且合理的选择
综述指出,皮下注射睾酮酯与肌内注射剂量相似时,药代动力学和平均血清睾酮水平相当;经适当培训,患者可安全自行皮下注射,不适感较肌内注射轻,且可能提高依从性。
要点
- 皮下注射与肌内注射睾酮酯剂量相似时,药代动力学和平均血清睾酮水平相当。
- 经适当培训,患者可安全自行皮下注射睾酮酯,且不适感较肌内注射轻。
- 临床医生应与患者讨论皮下注射途径,因其更易自行给药并可能提高依从性。
核心结论
- 皮下注射睾酮酯与肌内注射剂量相似时,药代动力学和平均血清睾酮水平相当。
- 经适当培训,患者可安全自行皮下注射睾酮酯,且不适感较肌内注射轻。
- 临床医生应与患者讨论皮下注射途径,因其更易自行给药并可能提高依从性。
研究设计与样本
- 系统综述现有皮下注射睾酮给药文献,包括临床试验、病例系列和病例报告。
- 同时综述皮下给药后睾酮吸收的药理学。
主要发现
- 现有证据有限,但提示皮下注射睾酮酯剂量与肌内注射相似时,药代动力学和平均血清睾酮水平相当。
- 经适当培训,患者可安全自行皮下注射睾酮酯,且相对容易、不适感较肌内注射轻。
临床怎么用
- 临床医生应与选择皮下注射途径的患者讨论该选项,因其更易自行给药并可能提高依从性。
局限性
- 现有数据有限。
- 缺乏直接比较皮下与肌内注射睾酮酯安全性的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Injections with intramuscular (IM) testosterone esters have been available for almost 8 decades and not only result in predictable serum testosterone levels but are also the most inexpensive modality. However, they are difficult to self-administer and associated with some discomfort. Recently, subcutaneous (SC) administration of testosterone esters has gained popularity, as self-administration is easier with this route. Available data, though limited, support the feasibility of this route. Here we review the pharmacokinetics and safety of SC testosterone therapy with both long- and ultralong-acting testosterone esters. In addition, we provide guidance for clinicians on how to counsel and manage their patients who opt for the SC route. EVIDENCE ACQUISITION: Systematic review of available literature on SC testosterone administration including clinical trials, case series, and case reports. We also review the pharmacology of testosterone absorption after SC administration. EVIDENCE SYNTHESIS: Available evidence, though limited, suggests that SC testosterone therapy in doses similar to those given via IM route results in comparable pharmacokinetics and mean serum testosterone levels. With appropriate training, patients should be able to safely self-administer testosterone esters SC with relative ease and less discomfort compared with the IM route. CONCLUSION: Although studies directly comparing the safety of SC vs IM administration of testosterone esters are desirable, clinicians should consider discussing the SC route with their patients because it is easier to self-administer and has the potential to improve patient adherence.
引用
- Figueiredo MG, Gagliano-Jucá T, Basaria S, et al. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option. J Clin Endocrinol Metab. 2022. PMID: 34698352. doi:10.1210/clinem/dgab772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。